BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 16777349)

  • 1. Reduced psychostimulant effects on dopamine dynamics in the nucleus accumbens of mu-opioid receptor knockout mice.
    Mathon DS; Vanderschuren LJ; Ramakers GM
    Neuroscience; 2006 Sep; 141(4):1679-84. PubMed ID: 16777349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased gabaergic input to ventral tegmental area dopaminergic neurons associated with decreased cocaine reinforcement in mu-opioid receptor knockout mice.
    Mathon DS; Lesscher HM; Gerrits MA; Kamal A; Pintar JE; Schuller AG; Spruijt BM; Burbach JP; Smidt MP; van Ree JM; Ramakers GM
    Neuroscience; 2005; 130(2):359-67. PubMed ID: 15664692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mu-opioid receptor knockout mice show diminished food-anticipatory activity.
    Kas MJ; van den Bos R; Baars AM; Lubbers M; Lesscher HM; Hillebrand JJ; Schuller AG; Pintar JE; Spruijt BM
    Eur J Neurosci; 2004 Sep; 20(6):1624-32. PubMed ID: 15355329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mu-Opioid receptor knockout mice display reduced cocaine conditioned place preference but enhanced sensitization of cocaine-induced locomotion.
    Hall FS; Goeb M; Li XF; Sora I; Uhl GR
    Brain Res Mol Brain Res; 2004 Feb; 121(1-2):123-30. PubMed ID: 14969743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased firing frequency of midbrain dopamine neurons in mice lacking mu opioid receptors.
    Mathon DS; Ramakers GM; Pintar JE; Marinelli M
    Eur J Neurosci; 2005 May; 21(10):2883-6. PubMed ID: 15926936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrasting effects of mu opioid receptor and delta opioid receptor deletion upon the behavioral and neurochemical effects of cocaine.
    Chefer VI; Kieffer BL; Shippenberg TS
    Neuroscience; 2004; 127(2):497-503. PubMed ID: 15262338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rewarding effects of ethanol and cocaine in mu opioid receptor-deficient mice.
    Becker A; Grecksch G; Kraus J; Loh HH; Schroeder H; Höllt V
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr; 365(4):296-302. PubMed ID: 11919654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rewarding properties of MDMA are preserved in mice lacking mu-opioid receptors.
    Robledo P; Mendizabal V; Ortuño J; de la Torre R; Kieffer BL; Maldonado R
    Eur J Neurosci; 2004 Aug; 20(3):853-8. PubMed ID: 15255997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unraveling dopamine D3 receptor function in response to psychostimulants using a genetic approach.
    Xu M
    Ann N Y Acad Sci; 1998 May; 844():27-39. PubMed ID: 9668662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shell/core differences in mu- and delta-opioid receptor modulation of dopamine efflux in nucleus accumbens.
    Hipólito L; Sánchez-Catalán MJ; Zanolini I; Polache A; Granero L
    Neuropharmacology; 2008 Aug; 55(2):183-9. PubMed ID: 18582908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of acute "binge" cocaine on mRNA levels of mu opioid receptor and neuropeptides in dopamine D1 or D3 receptor knockout mice.
    Zhou Y; Adomako-Mensah J; Yuferov V; Ho A; Zhang J; Xu M; Kreek MJ
    Synapse; 2007 Jan; 61(1):50-9. PubMed ID: 17068774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential activation of dopamine release in the nucleus accumbens core and shell after acute or repeated amphetamine injections: a comparative study in the Roman high- and low-avoidance rat lines.
    Giorgi O; Piras G; Lecca D; Corda MG
    Neuroscience; 2005; 135(3):987-98. PubMed ID: 16154292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine responsiveness to drugs of abuse: A shell-core investigation in the nucleus accumbens of the mouse.
    Zocchi A; Girlanda E; Varnier G; Sartori I; Zanetti L; Wildish GA; Lennon M; Mugnaini M; Heidbreder CA
    Synapse; 2003 Dec; 50(4):293-302. PubMed ID: 14556234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine release in the nucleus accumbens during heroin self-administration is modulated by kappa opioid receptors: an in vivo fast-cyclic voltammetry study.
    Xi ZX; Fuller SA; Stein EA
    J Pharmacol Exp Ther; 1998 Jan; 284(1):151-61. PubMed ID: 9435173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo evidence that genetic background controls impulse-dependent dopamine release induced by amphetamine in the nucleus accumbens.
    Ventura R; Alcaro A; Mandolesi L; Puglisi-Allegra S
    J Neurochem; 2004 Apr; 89(2):494-502. PubMed ID: 15056292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diazepam Inhibits Electrically Evoked and Tonic Dopamine Release in the Nucleus Accumbens and Reverses the Effect of Amphetamine.
    Gomez-A A; Fiorenza AM; Boschen SL; Sugi AH; Beckman D; Ferreira ST; Lee K; Blaha CD; Da Cunha C
    ACS Chem Neurosci; 2017 Feb; 8(2):300-309. PubMed ID: 28038309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A lack of mu-opioid receptors modulates the expressions of neuropeptide Y and substance P mRNA.
    Yoo JH; Cho JH; Lee SY; Loh HH; Ho IK; Jang CG
    Neurosci Lett; 2005 Aug 12-19; 384(1-2):29-32. PubMed ID: 15885902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered sensitivities to morphine and cocaine in scaffold protein tamalin knockout mice.
    Ogawa M; Miyakawa T; Nakamura K; Kitano J; Furushima K; Kiyonari H; Nakayama R; Nakao K; Moriyoshi K; Nakanishi S
    Proc Natl Acad Sci U S A; 2007 Sep; 104(37):14789-94. PubMed ID: 17766434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Voltammetric assessment of dopamine clearance in the absence of the dopamine transporter: no contribution of other transporters in core or shell of nucleus accumbens.
    Mateo Y; Budygin EA; John CE; Banks ML; Jones SR
    J Neurosci Methods; 2004 Dec; 140(1-2):183-7. PubMed ID: 15589348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in behavioural effects of amphetamine and dopamine-related gene expression in wild-type and homozygous CCK2 receptor deficient mice.
    Rünkorg K; Värv S; Matsui T; Kõks S; Vasar E
    Neurosci Lett; 2006 Oct; 406(1-2):17-22. PubMed ID: 16916582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.